Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis and lipoxins.

Iolanda M Fierro1

  • 1Departamento de Farmacologia e Psicobiologia, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil 20551-030. iolanda@uerj.br

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|June 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repositioning and investigational drugs for Zika virus infection treatment: a patent review.

Expert opinion on therapeutic patents·2020
Same author

New strategies for patenting biological medicines used in rheumatoid arthritis treatment.

Expert opinion on therapeutic patents·2018
Same author

Case study of patents related to captopril, Squibb's first blockbuster.

Expert opinion on therapeutic patents·2016
Same author

Overview of Flaxseed Patent Applications for the Reduction of Cholesterol Levels.

Recent patents on food, nutrition & agriculture·2016
Same author

Trends in Biotechnological Drugs for Cancer Treatment.

Recent patents on anti-cancer drug discovery·2015
Same author

Nanoparticles applied to antineoplastic agents: a patent landscape.

Pharmaceutical patent analyst·2014

Aspirin-triggered lipoxins (ATL) inhibit endothelial cell functions crucial for new blood vessel growth. These findings reveal novel vascular actions of ATL, impacting angiogenesis.

Area of Science:

  • Vascular biology and cell signaling
  • Lipid mediator pharmacology

Background:

  • Angiogenesis is vital for new blood vessel formation, involving endothelial cell (EC) migration, proliferation, and maturation.
  • Aspirin-triggered lipoxins (ATL) are endogenous lipid mediators with known immunomodulatory effects.

Purpose of the Study:

  • To investigate the effects of ATL on EC functions and angiogenesis.
  • To identify novel vascular actions of locally generated ATL and synthetic analogs.

Main Methods:

  • In vitro and in vivo studies assessing EC responses.
  • Evaluation of ATL's impact on key steps of the angiogenic process.

Main Results:

  • ATL were found to inhibit EC responses essential for angiogenesis.

Related Experiment Videos

  • Novel vascular actions of ATL in modulating blood vessel formation were identified.

    • Conclusions:

    • ATL and their synthetic analogs can inhibit endothelial cell functions involved in angiogenesis.
    • ATL possess previously unrecognized roles in regulating vascular processes.